Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:OII
NYSE:OIIEnergy Services

Oceaneering International (OII) Is Up 6.9% After Upbeat Subsea Robotics Outlook And Diversification Push

In recent days, Oceaneering International has attracted heightened attention as analysts raised earnings estimates and highlighted stronger demand across its subsea robotics and offshore services businesses. Investor interest has also been supported by the company’s push into defense and other non-energy applications, which is seen as enhancing diversification away from traditional offshore oil and gas cycles. We’ll now examine how this improving analyst sentiment around Oceaneering...
NYSE:AI
NYSE:AISoftware

A Look At C3.ai (AI) Valuation As Shares Struggle And Revenue Growth Remains Modest

How C3.ai’s Recent Performance Frames Today’s Investment Debate C3.ai (AI) has been trading under pressure, with the stock showing a 6% decline over the past month and a 22.9% decline over the past 3 months. This puts recent returns in sharp focus for investors. See our latest analysis for C3.ai. Short term, the 1 day and 7 day share price returns of 4.21% and 4.04% sit against a 1 year total shareholder return decline of 58.51%. This signals fading momentum despite the latest bounce from the...
NYSE:HSY
NYSE:HSYFood

How Investors May Respond To Hershey (HSY) Earnings Optimism And Its Record Of EPS Surprises

Hershey recently drew attention as analysts pointed to a favorable earnings outlook and the company’s history of exceeding consensus EPS estimates in the past four quarters, fueling expectations that its December 2025-quarter results, now in the rear-view mirror, might have outperformed projections. This combination of improving analyst sentiment and a consistent record of past earnings surprises has made Hershey’s earnings quality and reliability a central focus for investors assessing the...
OM:SSAB A
OM:SSAB AMetals and Mining

SSAB (OM:SSAB A) Margin Compression To 5.1% Tests Bullish Earnings Narratives

SSAB (OM:SSAB A) has wrapped up FY 2025 with fourth quarter revenue of SEK 22.1 billion and basic EPS of SEK 0.44, rounding out a trailing twelve month picture that includes SEK 96.2 billion in revenue and EPS of SEK 4.92. Over recent quarters the company has seen revenue move from SEK 25.5 billion and EPS of SEK 1.13 in Q1 2025 to SEK 25.6 billion and EPS of SEK 1.86 in Q2, then SEK 23.0 billion and EPS of SEK 1.49 in Q3 before landing at the latest Q4 result. This sets up a mixed but...
NYSE:CAVA
NYSE:CAVAHospitality

CAVA CEO Stock Sale Puts Growth Story And Risks In Spotlight

CAVA Group CEO and President Brett Schulman recently sold a significant block of NYSE:CAVA shares. The size of the sale has sparked fresh questions about executive confidence and investor sentiment toward the company. Insider transactions of this scale are drawing attention because they can influence how investors view near term prospects. CAVA Group, trading as NYSE:CAVA, last closed at $62.7, with the stock showing a 6.3% decline over the past week and a 4.6% gain over the past month...
NYSE:FLS
NYSE:FLSMachinery

Is It Too Late To Consider Flowserve (FLS) After Its Strong Multi‑Year Share Price Run?

If you are wondering whether Flowserve's share price still offers value after a strong run, or if you might be turning up late, this article walks through what the numbers are actually saying about the stock. Flowserve shares most recently closed at US$78.64, with returns of 0.1% over 7 days, 12.1% over 30 days, 11.2% year to date and 26.8% over 1 year, plus a very large 3 year and strong 5 year return profile. Recent attention on Flowserve has focused on how the business fits into demand...
NasdaqGS:MORN
NasdaqGS:MORNCapital Markets

Morningstar (MORN) Valuation Check After Launch Of PitchBook GenAI 20 Index

Morningstar (MORN) recently launched the Morningstar PitchBook GenAI 20 Index, a new benchmark that tracks pure-play generative AI companies across their journey from private ownership to public markets. See our latest analysis for Morningstar. Despite launching the PitchBook GenAI 20 Index and publishing fresh retirement research, Morningstar’s recent share price return has been weak, with a 30-day share price return decline of 7.69% and a 1-year total shareholder return loss of 38.67%,...
NYSE:WST
NYSE:WSTLife Sciences

Is West Pharmaceutical (WST) Refocusing on Larger-Volume SmartDose a Quiet Shift in Its Strategic Moat?

West Pharmaceutical Services recently announced a definitive agreement to sell all manufacturing and supply rights for its SmartDose® 3.5mL On-Body Delivery System to AbbVie for US$112.5 million, with potential milestone payments and an expected closing in mid-2026, while confirming it will report fourth-quarter and full-year 2025 results on February 12, 2026. The deal sharpens West’s focus on larger-volume drug delivery technologies, such as the SmartDose® 10mL platform, while updating...
ASX:RMS
ASX:RMSMetals and Mining

What Might Ramelius Resources' (ASX:RMS) Quiet Before Q2 2026 Earnings Reveal About Its Strategy?

Ramelius Resources has scheduled its Q2 2026 earnings call for January 29, 2026, a key update point for investors following the gold producer’s operational progress. The absence of other recent material announcements means this earnings call takes on added significance as a primary source of fresh information on the business. Against this backdrop, we’ll consider how anticipation around the upcoming Q2 2026 earnings call shapes Ramelius Resources’ broader investment narrative. The latest...
NasdaqGS:PFBC
NasdaqGS:PFBCBanks

Why Preferred Bank (PFBC) Is Down 9.1% After Mixed Signals In A Strong Q4 Earnings Beat

Preferred Bank reported past fourth-quarter 2025 results with net interest income of US$69.98 million and net income of US$34.82 million, both higher than the prior year, and full-year 2025 earnings per share also improved on both a basic and diluted basis. Beneath the headline beat, management flagged elevated deposit costs amid intense competition and a classified loan downgrade that could take up to two quarters to resolve, sharpening attention on funding and credit risk. We’ll now...
SEHK:9880
SEHK:9880Machinery

Assessing Ubtech Robotics (SEHK:9880) Valuation After New Intelligent Robotics Partnership Announcement

Why Ubtech Robotics is back on investors’ radar Ubtech Robotics (SEHK:9880) has drawn fresh attention after signing a Partnership Agreement on 22 January 2026 with Liuzhou Industrial Holding Fund and Liuzhou Industrial Guidance Fund to invest across the intelligent robot industry chain. See our latest analysis for Ubtech Robotics. At a latest share price of HK$142.3, Ubtech Robotics has delivered a 30 day share price return of 9.97% and a 1 year total shareholder return of 99.58%. This...
NYSE:TXT
NYSE:TXTAerospace & Defense

Textron (TXT) Earnings Growth Outpaces Sales And Supports Steady Margin Narrative

Textron (TXT) has wrapped up FY 2025 with Q4 revenue of US$4.2b and basic EPS of US$1.33, alongside trailing twelve month revenue of US$14.8b and EPS of US$5.12. Over recent periods, revenue has moved from US$3.6b in Q4 2024 to US$4.2b in Q4 2025, while quarterly EPS shifted from US$0.76 to US$1.33, with trailing EPS moving in a tighter range between about US$4.38 and US$5.12. With net profit margins holding in the low single digits and edging higher year on year, the latest numbers point to...
TSE:4552
TSE:4552Pharmaceuticals

JCR Pharmaceuticals (TSE:4552) Q3 EPS Slide Challenges Bullish Profit Recovery Narrative

JCR Pharmaceuticals (TSE:4552) has reported Q3 2026 revenue of ¥8,991 million and basic EPS of ¥0.28, alongside net income excluding extra items of ¥34 million, setting a measured tone for the latest update. The company has seen quarterly revenue move between ¥8,512 million and ¥12,793 million over the past five reported periods, while basic EPS has ranged from a loss of ¥34.28 per share to a profit of ¥18.50 per share, giving investors a clear view of how earnings have been fluctuating...
NYSE:BRO
NYSE:BROInsurance

Brown And Brown Weighs Legal Transition With Expanded Capital Returns

Brown & Brown (NYSE:BRO) announced the passing of Chief Legal Officer Robert Mathis, a long serving executive and key legal leader. The company appointed Eileen Akerson as interim Chief Legal Officer as it evaluates longer term leadership plans for the role. The board approved a higher quarterly dividend for the 32nd consecutive year and expanded the existing share repurchase authorization. For investors watching NYSE:BRO, these updates come with the stock at $72.1, with a 3 year return of...